Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. (XLO) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
xlo · market cap & enterprise value · FMP · as of Jun 8, 2026
Core market cap & key metrics
As of Jun 8, 2026, Xilio Therapeutics, Inc. (XLO) has a market cap — also referred to as its net worth or valuation — of $45,948,204, making it one of the top most valuable companies globally. Market Cap = $7.68 × shares outstanding.
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Xilio Therapeutics, Inc. (XLO) has a market cap — also referred to as its net worth or valuation — of $45,948,204 as of Jun 8, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Xilio Therapeutics, Inc. reached its all-time high market cap of $0 on —. Comparing the Xilio Therapeutics, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Xilio Therapeutics, Inc. net worth vs peers and ask how Xilio Therapeutics, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
XLO market cap · 6 questionsXilio Therapeutics, Inc.'s net worth — measured as market capitalization — is $45,948,204 as of Jun 8, 2026. It ranks #0 globally. Market Cap = $$7.68 (price) × shares outstanding.